Small Stocks, Big Money™

Nova Minerals (Nasdaq: NVA) has confirmed an 800m x 400m antimony-rich zone at its Stibium prospect, part of the Estelle Gold and Critical Minerals Project in Alaska. Rock samples returned grades as high as 56.7% Sb, with 11 samples exceeding 30% Sb. This discovery positions Nova as a key player in the U.S. critical minerals supply chain, especially as antimony—vital for defense and energy technologies—faces restricted exports from China. The company is advancing toward resource definition and pursuing U.S. government grant funding to fast-track development.

Can-Fite BioPharma (NYSE American: CANF) announced a remarkable 8-year survival with complete tumor response in a patient treated with Namodenoson during a Phase II liver cancer study. This patient continues to experience normal liver function and high quality of life. Currently in a pivotal Phase III trial for advanced hepatocellular carcinoma (HCC), Namodenoson targets tumor cells while sparing healthy liver tissue. With FDA Fast Track and Orphan Drug status, the drug aims to address the $6.1 billion HCC treatment market.

Sharps Technology (Nasdaq: STSS) announced a transformative $50M+ five-year sales agreement with a U.S.-based pharma company, committing to supply 500M 10mL SoloGard syringes from its Hungary facility starting Q1 2025. Additionally, new European agreements for its SecureGard syringes are driving immediate revenue, with December sales expected to reach $400K and annual revenues projected to exceed $20M by 2027. To meet surging demand for its innovative safety syringe products, Sharps is expanding its Hungary facility and exploring collaborations with local investors. With NASDAQ compliance restored and a U.S. facility acquisition in progress, Sharps is positioned for significant growth in the global syringe market.

VSee Health (Nasdaq: VSEE) and AbundaBox have launched AbundaLife™, a unified health record platform designed to eliminate fragmented medical data and improve care coordination. At just $34 annually per patient, this scalable solution integrates records, prescriptions, lab results, and more into a single secure profile, enhancing care personalization and reducing errors. Built on VSee Health’s advanced telehealth technology, AbundaLife has already attracted eight healthcare facilities, signaling strong early adoption. By combining innovation and affordability, this partnership aims to transform healthcare access and efficiency nationwide.